These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32780510)

  • 1. Ascorbic acid supplementation attenuates schizophrenia-like symptoms in an animal model induced by ketamine.
    Supp AD; Avila S; Mastella GA; Damásio L; de Oliveira IH; Godoi AK; Michels A; Schuck PF; Zugno AI
    Int J Dev Neurosci; 2021 Feb; 81(1):26-36. PubMed ID: 32780510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.
    Damazio LS; Silveira FR; Canever L; Castro AA; Estrela JM; Budni J; Zugno AI
    An Acad Bras Cienc; 2017; 89(2):1133-1141. PubMed ID: 28513779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of maternal folic acid supplementation on nuclear methyltransferase activity of adult rats subjected to an animal model of schizophrenia.
    Canever L; Varela R; Mastella GA; Damázio LS; Valvassori SS; Quevedo JL; Zugno AI
    Int J Dev Neurosci; 2021 Aug; 81(5):461-467. PubMed ID: 33786893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine.
    Zugno AI; Canever L; Heylmann AS; Wessler PG; Steckert A; Mastella GA; de Oliveira MB; Damázio LS; Pacheco FD; Calixto OP; Pereira FP; Macan TP; Pedro TH; Schuck PF; Quevedo J; Budni J
    J Psychiatr Res; 2016 Oct; 81():23-35. PubMed ID: 27367209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
    Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
    Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: The effects of FA deficient or FA supplemented diet during the neurodevelopmental phase.
    Canever L; Freire TG; Mastella GA; Damázio L; Gomes S; Fachim I; Michels C; Carvalho G; Godói AK; Peterle BR; Gava FF; Valvassori SS; Budni J; Quevedo J; Zugno AI
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():52-64. PubMed ID: 29782958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sepsis on behavioral changes on the ketamine-induced animal model of schizophrenia.
    Comim CM; Silva NC; Patrício JJ; Palmas D; Mendonça BP; Bittencourt MO; Cassol OJ; Barichello T; Zugno AI; Quevedo J; Dal-Pizzol F
    J Neuroimmunol; 2015 Apr; 281():78-82. PubMed ID: 25867472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes.
    Canever L; Oliveira L; D'Altoé de Luca R; Correa PT; de B Fraga D; Matos MP; Scaini G; Quevedo J; Streck EL; Zugno AI
    Oxid Med Cell Longev; 2010; 3(6):421-7. PubMed ID: 21270541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia.
    Zugno AI; Canever L; Mastella G; Heylmann AS; Oliveira MB; Steckert AV; Castro AA; dal Pizzol F; Quevedo J; Gama CS
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1475-86. PubMed ID: 26397829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
    Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
    Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.
    Canever L; Alves CSV; Mastella G; Damázio L; Polla JV; Citadin S; De Luca LA; Barcellos AS; Garcez ML; Quevedo J; Budni J; Zugno AI
    Mol Neurobiol; 2018 Mar; 55(3):2301-2319. PubMed ID: 28342013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
    Zugno AI; Julião RF; Budni J; Volpato AM; Fraga DB; Pacheco FD; Deroza PF; Luca RD; de Oliveira MB; Heylmann AS; Quevedo J
    Metab Brain Dis; 2013 Sep; 28(3):501-8. PubMed ID: 23775300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketamine on lipopolysaccharide-induced depressive-like behavior and the expression of inflammatory cytokines in the rat prefrontal cortex.
    Yang C; Shen J; Hong T; Hu TT; Li ZJ; Zhang HT; Zhang YJ; Zhou ZQ; Yang JJ
    Mol Med Rep; 2013 Sep; 8(3):887-90. PubMed ID: 23900245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical investigation of Diabetes Mellitus as a risk factor for schizophrenia.
    Heylmann ASA; Canever L; Gress K; Gomes ST; Fachim I; Michels C; Stopassoli GC; Mastella GA; Steckert AV; Damiani AP; de Andrade VM; Quevedo J; Zugno AI
    Behav Brain Res; 2017 May; 326():154-164. PubMed ID: 28286284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine potentiates oxidative stress and influences behavior and inflammation in response to lipolysaccharide (LPS) exposure in early life.
    Réus GZ; Simões LR; Colpo GD; Scaini G; Oses JP; Generoso JS; Prossin AR; Kaddurah-Daouk R; Quevedo J; Barichello T
    Neuroscience; 2017 Jun; 353():17-25. PubMed ID: 28433652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats.
    de Oliveira L; Spiazzi CM; Bortolin T; Canever L; Petronilho F; Mina FG; Dal-Pizzol F; Quevedo J; Zugno AI
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1003-8. PubMed ID: 19454299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
    Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
    Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketamine on prepubertal Wistar rats: Implications on behavioral parameters for Childhood-Onset Schizophrenia.
    Damazio Pacheco F; Canever L; Antunes Mastella G; Gomes Wessler P; Kunz Godoi A; Hubbe I; da Costa Afonso A; Celso D; Quevedo J; Ioppi Zugno A
    Int J Dev Neurosci; 2019 Dec; 79():49-53. PubMed ID: 31678549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Intake of Ascorbic Acid Attenuates Lipopolysaccharide-Induced Sepsis and Septic Inflammation in ODS Rats.
    Kawade N; Tokuda Y; Tsujino S; Aoyama H; Kobayashi M; Murai A; Horio F
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):404-411. PubMed ID: 30606963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophrenia.
    Zugno AI; Chipindo H; Canever L; Budni J; Alves de Castro A; Bittencourt de Oliveira M; Heylmann AS; Gomes Wessler P; da Rosa Silveira F; Damázio LS; Mastella GA; Kist LW; Bogo MR; Quevedo J; Gama CS
    Life Sci; 2015 Jan; 121():65-9. PubMed ID: 25498892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.